The current valuation score of Phathom Pharmaceuticals Inc is 8.58, ranking 51 out of 155 in the Pharmaceuticals industry. Its current P/E ratio is -4.18, which is -89.43% below the recent high of -0.44 and -49.14% above the recent low of -6.23.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.